NeurAxis: Should You Buy This IPO? By: TalkMarkets February 08, 2023 at 12:14 PM EST As NeurAxis is ready to launch its IPO, we take a closer look to see if investors should be buying into the hype. Read More >> Related Stocks: AbbVie Amgen Arena Pharmaceuticals, Inc. - Common Stock Bristol-Myers Squibb Gilead Sciences Masimo Corporation - Common Stock Pfizer Takeda Pharmaceutical Company Limited American Depositary Shares (each
